Predicted protein targets (top 20)
| gene | UniProt | supporting neighbours | confidence | |
|---|---|---|---|---|
| ▸ | MAOB | P27338 | 7/20 | 0.42 |
| ▸ | MAOA | P21397 | 6/20 | 0.42 |
| ▸ | AOC2 | O75106 | 5/20 | 0.42 |
| ▸ | CHRM2 | P08172 | 2/20 | 0.42 |
| ▸ | CHRM4 | P08173 | 2/20 | 0.42 |
| ▸ | CHRM5 | P08912 | 2/20 | 0.42 |
| ▸ | CHRM1 | P11229 | 2/20 | 0.42 |
| ▸ | CHRM3 | P20309 | 2/20 | 0.42 |
| ▸ | DAO | P14920 | 1/20 | 0.42 |
| ▸ | HPGD | P15428 | 1/20 | 0.42 |
| ▸ | TSHR | P16473 | 1/20 | 0.42 |
| ▸ | NISCH | Q9Y2I1 | 1/20 | 0.40 |
| ▸ | HRH3 | Q9Y5N1 | 1/20 | 0.39 |
| ▸ | KDM4E | B2RXH2 | 1/20 | 0.37 |
| ▸ | ADORA3 | P0DMS8 | 1/20 | 0.37 |
| ▸ | AR | P10275 | 1/20 | 0.37 |
| ▸ | CYP19A1 | P11511 | 1/20 | 0.37 |
| ▸ | HSD17B10 | Q99714 | 1/20 | 0.37 |
| ▸ | NFKB1 | P19838 | 1/20 | 0.36 |
| ▸ | NFKB2 | Q00653 | 1/20 | 0.36 |
Click a target to see other patent compounds predicted against it — the reverse direction, in place.
Similar compounds — the chemically nearest patent molecules
Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.
| Compound | similarity | top predicted | shared targets | |
|---|---|---|---|---|
| SCHEMBL29935960 | 1.00 | MAOB (0.42) | MAOBMAOAAOC2CHRM2CHRM4 | |
| SCHEMBL10698516 | 0.80 | MAOB (0.39) | MAOBMAOAAOC2CHRM2CHRM4 | |
| SCHEMBL2713231 | 0.80 | MAOA (0.43) | MAOBMAOAAOC2CHRM2CHRM4 | |
| SCHEMBL5572317 | 0.77 | MAOA (0.38) | MAOBMAOAAOC2CHRM2CHRM4 | |
| SCHEMBL31015921 | 0.77 | CHRM2 (0.40) | MAOBMAOAAOC2CHRM2CHRM4 | |
| SCHEMBL14837286 | 0.77 | TSHR (0.39) | CHRM2CHRM4CHRM5CHRM1CHRM3 | |
| SCHEMBL22474472 | 0.76 | CHRM2 (0.42) | MAOBMAOAAOC2CHRM2CHRM4 | |
| SCHEMBL11215570 | 0.76 | HSP90AB1 (0.44) | MAOBMAOAAOC2CHRM2CHRM4 | |
| SCHEMBL5779685 | 0.74 | MAOB (0.41) | MAOBMAOAAOC2CHRM2CHRM4 | |
| SCHEMBL3663270 | 0.74 | MAOA (0.45) | MAOBMAOAAOC2CHRM2CHRM4 |
Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.
Patent provenance — the patents this molecule appears in, and who filed them
Claimed or disclosed in 23 patents — showing the first 20. claimed = in the patent's claims; disclosed = body only.
| Patent | Title | Assignee | Published | Priority | Filing | Country | Status |
|---|---|---|---|---|---|---|---|
| CN-118638106-A | Novel method for synthesizing hexamethylation sophoraflavanone J | 西南交通大学 | 2024-09-13 | — | — | CN | disclosed |
| CN-118234730-A | Heterocyclic NLRP3 inhibitors | 豪夫迈·罗氏有限公司 | 2024-06-21 | — | — | CN | disclosed |
| CN-110452201-A | A kind of synthetic method of benzofurans heterocyclic sulfonyl chloride | TAIZHOU POLYTECHNIC COLLEGE | 2019-11-15 | — | — | CN | disclosed |
| CN-107216336-A | Camptothecine compounds and its preparation and use | 李雨亮 | 2017-09-29 | — | — | CN | disclosed |
| CN-106986865-A | On Mental disease or the compound and medical composition of malignant tumour | 国立大学法人京都大学 | 2017-07-28 | — | — | CN | disclosed |
| CN-106660982-A | Histone demethylase inhibitors | 赛尔基因昆蒂赛尔研究公司 | 2017-05-10 | — | — | CN | disclosed |
| CN-104045625-A | INDOLE AND INDAZOLE COMPOUNDS THAT ACTIVATE AMPK | PFIZER | 2014-09-17 | — | — | CN | disclosed |
| CN-103509030-A | Camptothecin compound and preparation and application thereof | LI YULIANG | 2014-01-15 | — | — | CN | disclosed |
| EP-0841925-B1 | ENDOTHELIN RECEPTOR ANTAGONISTS | SMITHKLINE BEECHAM CORP (US) | 2006-10-04 | — | — | EP | disclosed |
| US-6482956-B2 | FOR THERAPY OF CARDIOVASCULAR, CEREBROVASCULAR, RESPIRATORY AND RENAL DISORDERS | SMITHKLINE BEECHAM CORPORATION | 2002-11-19 | — | — | US | disclosed |
| EP-1036062-A1 | HYDROXAMIC ACID DERIVATIVES AS MATRIX METALLOPROTEASE (MMP) INHIBITORS | Pfizer Limited (GB) | 2000-09-20 | — | — | EP | disclosed |
| US-6096897-A | NOVEL 1,2,3-TRIAZOLES | SMITHKLINE BEECHAM CORPORATION (US) | 2000-08-01 | — | — | US | disclosed |
| US-5969151-A | PYRAZOLE COMPOUNDS | SMITHKLINE BEECHAM CORPORATION (US) | 1999-10-19 | — | — | US | disclosed |
| US-5958968-A | CARDIOVASCULAR DISORDERS; KIDNEY DIEASES | SMITHKLINE BEECHAM CORPORATION (US) | 1999-09-28 | — | — | US | disclosed |
| WO-1999029667-A1 | HYDROXAMIC ACID DERIVATIVES AS MATRIX METALLOPROTEASE (MMP) INHIBITORS | PFIZER LIMITED (GB) | 1999-06-17 | — | — | WO | disclosed |
| CN-1196680-A | Endothelin receptor antagonists | SMITHKLINE BEECHAM CORP (US) | 1998-10-21 | — | — | CN | disclosed |
| EP-0841925-A1 | ENDOTHELIN RECEPTOR ANTAGONISTS | SMITHKLINE BEECHAM CORPORATION (US) | 1998-05-20 | — | — | EP | disclosed |
| WO-1997004772-A1 | ENDOTHELIN RECEPTOR ANTAGONISTS | SMITHKLINE BEECHAM CORPORATION (US) | 1997-02-13 | — | — | WO | disclosed |
| CN-1007248-B | PROCESS FOR MANUFACTURING OF FLOOD SUGAR REDUCING MEDICINE-THIAZOLIDINEDIONS | PFIZER (US) | 1990-03-21 | — | — | CN | disclosed |
| CN-86104075-A | Preparation method of hypoglycemic agent-thiazolidinedione | — | 1987-03-11 | — | — | CN | disclosed |